Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

9 Jun 2022 07:00

RNS Number : 2258O
Sopheon PLC
09 June 2022
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, holds its Annual General Meeting ("AGM") today. The Board takes this opportunity to give shareholders the following update and review of the business.

 

2021 in review

 

Our 2021 performance was gratifying both for the strategic progress we made and for exceeding our financial market expectations despite the continued market uncertainty. Both recognized revenues and annual recurring revenues ("ARR") grew by approximately 15% to $34.4m and $20.7m respectively. We remind shareholders that we are on a journey of transition from a traditional perpetual software license business to a higher-quality recurring revenue business. The goal is to deliver more predictable and reliable growth over the medium term; in the shorter term, this transition naturally weighs on profits as we accelerate go-to-market investment while simultaneously shifting software revenue recognition from an up-front to a rateable model. It was therefore very encouraging to also show continued profitability with both EBITDA and net cash growing. In addition to our financial results, 2021 was a year of unusually high activity and change for Sopheon. We appointed a new CEO, Greg Coticchia, and also strengthened our leadership team with appointments in key marketing, sales, and product areas. We have introduced and driven three key programs to support our strategic direction to:

 

· Transition our customer base and new sales engine to Software-as-a-Service ("SaaS"). By year end, 90 percent of the new customer pipeline by value was SaaS focused.

 

· Embrace a multi-product future by introducing new cloud-based applications. These new applications are intended to drive lead generation for our Accolade enterprise solution, as well as being stand-alone solutions that solve individual and workgroup productivity needs. At year end we completed the acquisition of ROI Blueprints, which is already playing a material role in both existing and new customer opportunities.

 

· Extend market reach beyond the very largest customers and thereby improve scalability and predictability. We made significant investments in marketing which are already increasing our metrics for market reach, prospect engagement and ultimately lead generation.

 

2022 update and outlook

 

Our most recent acquisition of Solverboard, announced in May 2022, accelerates our SaaS strategy from both functional and go-to-market perspectives. Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers. We expect to further develop Solverboard's product sales led distribution capabilities and introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

 

In parallel with our strategic progress, we have continued delivering growth in our core business. Since the start of the year, we have closed six new customer wins - compared to ten in the whole of 2021. All six were SaaS. ARR has risen to $21.7m compared to $19m a year ago, and gross retention has held above 98% on a year-to-date basis. These metrics demonstrate continued success with our transition towards a more recurring revenue model - which in turn improves our multi-year visibility and predictability. A lower share of one-off revenue contributions from perpetual and consulting sales year to date means that full year visibility for recognizable 2022 revenue is currently at $28m, a similar level to this time last year. Confidence in our full year performance is sustained by a sales pipeline that includes several major extensions with existing customers, alongside a growing list of new prospects. Net cash at the end of May stood at $25m compared to $23m at this time last year, underlining our cash generative nature and our ability to execute.

 

Sopheon's Chairman Andy Michuda said: "Sopheon's shift towards a pure play SaaS model and associated ARR growth is moving forward as planned, supported by delivery of two key acquisitions in ROI Blueprints and most recently Solverboard. We see growing commercial traction on both sides of the Atlantic, responding to our broader product offering and our more assertive marketing investment, and we remain focused on exploring other additive M&A opportunities."

 

For further information contact:

 

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)Alice Lane/Sunila da Silva (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

Sopheon, Accolade and Solverboard are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSRRDITIIF
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.